FDA's First "Bad Ad" Citation Goes To Hill Dermaceuticals
This article was originally published in The Pink Sheet Daily
Executive Summary
Program aimed at encouraging doctors to report promotions they find worrisome generates a DDMAC warning letter about a Web site for Derma-Smoothe.